139 related articles for article (PubMed ID: 29599315)
21. Melatonin reverses tunicamycin-induced endoplasmic reticulum stress in human hepatocellular carcinoma cells and improves cytotoxic response to doxorubicin by increasing CHOP and decreasing survivin.
Fan L; Sun G; Ma T; Zhong F; Lei Y; Li X; Wei W
J Pineal Res; 2013 Sep; 55(2):184-94. PubMed ID: 23711089
[TBL] [Abstract][Full Text] [Related]
22. Casein Kinase 2α Enhances 5-Fluorouracil Resistance in Colorectal Cancer Cells by Inhibiting Endoplasmic Reticulum Stress.
Kim HJ; Han YS; Lee JH; Lee SH
Anticancer Res; 2020 Mar; 40(3):1419-1426. PubMed ID: 32132038
[TBL] [Abstract][Full Text] [Related]
23. Dihydromyricetin reverses MRP2-mediated MDR and enhances anticancer activity induced by oxaliplatin in colorectal cancer cells.
Wang Z; Sun X; Feng Y; Liu X; Zhou L; Sui H; Ji Q; E Q; Chen J; Wu L; Li Q
Anticancer Drugs; 2017 Mar; 28(3):281-288. PubMed ID: 27997436
[TBL] [Abstract][Full Text] [Related]
24. Autophagy contributes to the enrichment and survival of colorectal cancer stem cells under oxaliplatin treatment.
Yang HZ; Ma Y; Zhou Y; Xu LM; Chen XJ; Ding WB; Zou HB
Cancer Lett; 2015 May; 361(1):128-36. PubMed ID: 25749420
[TBL] [Abstract][Full Text] [Related]
25. Impressive Suppression of Colon Cancer Growth by Triple Combination SN38/EF24/Melatonin: "Oncogenic"
Bakalova R; Zhelev Z; Shibata S; Nikolova B; Aoki I; Higashi T
Anticancer Res; 2017 Oct; 37(10):5449-5458. PubMed ID: 28982855
[TBL] [Abstract][Full Text] [Related]
26. Protective effect of melatonin on oxaliplatin-induced apoptosis through sustained Mcl-1 expression and anti-oxidant action in renal carcinoma Caki cells.
Um HJ; Kwon TK
J Pineal Res; 2010 Oct; 49(3):283-90. PubMed ID: 20626587
[TBL] [Abstract][Full Text] [Related]
27. The glutamate transport inhibitor DL-Threo-β-Benzyloxyaspartic acid (DL-TBOA) differentially affects SN38- and oxaliplatin-induced death of drug-resistant colorectal cancer cells.
Pedraz-Cuesta E; Christensen S; Jensen AA; Jensen NF; Bunch L; Romer MU; Brünner N; Stenvang J; Pedersen SF
BMC Cancer; 2015 May; 15():411. PubMed ID: 25981639
[TBL] [Abstract][Full Text] [Related]
28. Does doxycycline work in synergy with cisplatin and oxaliplatin in colorectal cancer?
Sagar J; Sales K; Dijk S; Taanman J; Seifalian A; Winslet M
World J Surg Oncol; 2009 Jan; 7():2. PubMed ID: 19126215
[TBL] [Abstract][Full Text] [Related]
29. Combination of cyclooxygenase-2 inhibitors and oxaliplatin increases the growth inhibition and death in human colon cancer cells.
Lin J; Hsiao PW; Chiu TH; Chao JI
Biochem Pharmacol; 2005 Sep; 70(5):658-67. PubMed ID: 16004971
[TBL] [Abstract][Full Text] [Related]
30. Cetuximab sensitivity associated with oxaliplatin resistance in colorectal cancer.
Ekblad L; Johnsson A
Anticancer Res; 2012 Mar; 32(3):783-6. PubMed ID: 22399593
[TBL] [Abstract][Full Text] [Related]
31. Oxaliplatin induces different cellular and molecular chemoresistance patterns in colorectal cancer cell lines of identical origins.
Virag P; Fischer-Fodor E; Perde-Schrepler M; Brie I; Tatomir C; Balacescu L; Berindan-Neagoe I; Victor B; Balacescu O
BMC Genomics; 2013 Jul; 14():480. PubMed ID: 23865481
[TBL] [Abstract][Full Text] [Related]
32. Rapamycin enhanced the antitumor efficacy of oxaliplatin in cisplatin-resistant ovarian cancer cells A2780cis both in vitro and in vivo.
Liu J; Zhang L; Zhang X; Xing X
J Chemother; 2015; 27(6):358-64. PubMed ID: 25976336
[TBL] [Abstract][Full Text] [Related]
33. P53-mediated upregulation of DcR1 impairs oxaliplatin/TRAIL-induced synergistic anti-tumour potential in colon cancer cells.
Toscano F; Fajoui ZE; Gay F; Lalaoui N; Parmentier B; Chayvialle JA; Scoazec JY; Micheau O; Abello J; Saurin JC
Oncogene; 2008 Jul; 27(30):4161-71. PubMed ID: 18345033
[TBL] [Abstract][Full Text] [Related]
34. The anticancer effect of (1S,2S,3E,7E,11E)-3,7,11, 15-cembratetraen-17,2-olide(LS-1) through the activation of TGF-β signaling in SNU-C5/5-FU, fluorouracil-resistant human colon cancer cells.
Kim EJ; Kang JI; Kwak JW; Jeon CH; Tung NH; Kim YH; Choi CH; Hyun JW; Koh YS; Yoo ES; Kang HK
Mar Drugs; 2015 Mar; 13(3):1340-59. PubMed ID: 25786063
[TBL] [Abstract][Full Text] [Related]
35. Nuclear orphan receptor NR4A2 confers chemoresistance and predicts unfavorable prognosis of colorectal carcinoma patients who received postoperative chemotherapy.
Han Y; Cai H; Ma L; Ding Y; Tan X; Liu Y; Su T; Yu Y; Chang W; Zhang H; Fu C; Cao G
Eur J Cancer; 2013 Nov; 49(16):3420-30. PubMed ID: 23809767
[TBL] [Abstract][Full Text] [Related]
36. Melatonin prevents mitochondrial dysfunction and promotes neuroprotection by inducing autophagy during oxaliplatin-evoked peripheral neuropathy.
Areti A; Komirishetty P; Akuthota M; Malik RA; Kumar A
J Pineal Res; 2017 Apr; 62(3):. PubMed ID: 28118492
[TBL] [Abstract][Full Text] [Related]
37. Glucose deprivation induces chemoresistance in colorectal cancer cells by increasing ATF4 expression.
Hu YL; Yin Y; Liu HY; Feng YY; Bian ZH; Zhou LY; Zhang JW; Fei BJ; Wang YG; Huang ZH
World J Gastroenterol; 2016 Jul; 22(27):6235-45. PubMed ID: 27468213
[TBL] [Abstract][Full Text] [Related]
38. PKM2 Subcellular Localization Is Involved in Oxaliplatin Resistance Acquisition in HT29 Human Colorectal Cancer Cell Lines.
Ginés A; Bystrup S; Ruiz de Porras V; Guardia C; Musulén E; Martínez-Cardús A; Manzano JL; Layos L; Abad A; Martínez-Balibrea E
PLoS One; 2015; 10(5):e0123830. PubMed ID: 25955657
[TBL] [Abstract][Full Text] [Related]
39. MEG3 is a prognostic factor for CRC and promotes chemosensitivity by enhancing oxaliplatin-induced cell apoptosis.
Li L; Shang J; Zhang Y; Liu S; Peng Y; Zhou Z; Pan H; Wang X; Chen L; Zhao Q
Oncol Rep; 2017 Sep; 38(3):1383-1392. PubMed ID: 28731151
[TBL] [Abstract][Full Text] [Related]
40. Melatonin protects mesenchymal stem cells from autophagy-mediated death under ischaemic ER-stress conditions by increasing prion protein expression.
Lee JH; Yoon YM; Han YS; Jung SK; Lee SH
Cell Prolif; 2019 Mar; 52(2):e12545. PubMed ID: 30430685
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
